TCL Archive Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients November 27, 2009
TCL Archive Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications March 18, 1977
TCL Archive Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time December 30, 2011
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006